Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players
- PMID: 19093957
- DOI: 10.1111/j.1365-2796.2008.02046.x
Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players
Abstract
Human immunodeficiency virus-1 (HIV-1) infection occurs primarily via genital mucosal tissues and the cellular mechanisms that affect HIV-1 acquisition are largely unclear. Langerhans cells (LCs) are professional antigen presenting cells lining the mucosal stratified squamous epithelium. It is becoming evident that LCs have different functions in HIV-1 transmission. HIV-1 can infect mucosal LCs, which subsequently efficiently transmit the virus to T cells in the lymphoid tissues. However, this seems to be dependent on the activation status of LCs, as immature LCs prevent HIV-1 infection by clearing invading HIV-1 though the C-type lectin langerin. Recent data demonstrate that co-infections with sexual transmitted infection (STIs) negate the protective function of LCs by different mechanisms, thereby allowing LC infection with HIV-1 and subsequently HIV-1 transmission. Here, we will discuss the function of LCs under normal circumstances and in the presence of STIs or inflammation. A better understanding of LCs function during homeostasis and inflammation is necessary for the development of new strategies to prevent HIV-1 infection.
Similar articles
-
Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission.Trends Mol Med. 2008 Jan;14(1):12-9. doi: 10.1016/j.molmed.2007.11.001. Epub 2007 Dec 4. Trends Mol Med. 2008. PMID: 18055263 Review.
-
Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function.J Immunol. 2010 Aug 1;185(3):1633-41. doi: 10.4049/jimmunol.0904137. Epub 2010 Jun 30. J Immunol. 2010. PMID: 20592277
-
Langerin is a natural barrier to HIV-1 transmission by Langerhans cells.Nat Med. 2007 Mar;13(3):367-71. doi: 10.1038/nm1541. Epub 2007 Mar 4. Nat Med. 2007. PMID: 17334373
-
The role of Langerhans cells in the sexual transmission of HIV.J Dermatol Sci. 2005 Dec;40(3):147-55. doi: 10.1016/j.jdermsci.2005.08.009. Epub 2005 Oct 13. J Dermatol Sci. 2005. PMID: 16226431 Review.
-
Mutz-3-derived Langerhans cells are a model to study HIV-1 transmission and potential inhibitors.J Leukoc Biol. 2010 Apr;87(4):637-43. doi: 10.1189/jlb.0809577. Epub 2009 Dec 30. J Leukoc Biol. 2010. PMID: 20042470
Cited by
-
Algal lectins as potential HIV microbicide candidates.Mar Drugs. 2012 Jul;10(7):1476-1497. doi: 10.3390/md10071476. Epub 2012 Jul 10. Mar Drugs. 2012. PMID: 22851920 Free PMC article. Review.
-
Regulation of adaptive immunity by the innate immune system.Science. 2010 Jan 15;327(5963):291-5. doi: 10.1126/science.1183021. Science. 2010. PMID: 20075244 Free PMC article. Review.
-
Circumcision plus antibiotic, anti-inflammatory, and α-blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial.World J Urol. 2015 May;33(5):617-22. doi: 10.1007/s00345-014-1350-1. Epub 2014 Jul 1. World J Urol. 2015. PMID: 24980414 Clinical Trial.
-
Human immature Langerhans cells restrict CXCR4-using HIV-1 transmission.Retrovirology. 2014 Jul 2;11:52. doi: 10.1186/1742-4690-11-52. Retrovirology. 2014. PMID: 24990163 Free PMC article.
-
Semen: A modulator of female genital tract inflammation and a vector for HIV-1 transmission.Am J Reprod Immunol. 2021 Nov;86(5):e13478. doi: 10.1111/aji.13478. Epub 2021 Jun 16. Am J Reprod Immunol. 2021. PMID: 34077596 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical